Division of Pharmaceutical Technology and Biopharmacy
Division of Pharmaceutical Technology and Biopharmacy
Division of Pharmaceutical Technology and Biopharmacy
Prof. Dr. Dagmar Fischer
The Fischer group is focussed on the development of natural and synthetic micro- and nanocarriers for drug delivery in the field of infection, inflammation and inflammation-related diseases as well as aging. A major focus is related to biopharmaceutical test systems according to the 3R principle to investigate the life cycle of drug delivery systems and the influence of the physiological environment. Furthermore, nanosafety and safe-by-design concepts as well as quality assurance concepts are provided
Lehrstuhl für Pharmazeutische Technologie und Biopharmazie, FAU Erlangen-Nürnberg
Donnerstag, 30. Januar 2025, 18:00 Uhr c.t.
Prof. Dr. Dagmar Fischer
Von Biofilmen und Hühnereiern: Nanopartikel als Hoffnung bei Mukoviszidose?
Der Vortrag findet um 18.00 Uhr c.t. im Hörsaal C2 des Chemikums, Ni...
At 16 January 2025 Anna-Lena Funk sucessfully defended her PhD thesis entiteled „Combination of Fentanyl with an Antidote in Transdermal Delivery Systems as an Anti-Abuse-Strategy“. Congratulations!
The new Pharmakon (1/2025) highlights the role of sustainability in pharmacy.
We support this with our article:
Use of Sustainable Materials in Pharmaceutical Formulations (S. Hübner, C. Kroh, D. Fischer)
The production of pharmaceutical formulations and their excipient...
Nadja Kohler sucessfully defended her PhD thesis entiteled „Austausch von Rohstoffen der lipophilen Phase und des Emulgators in halbfesten Zubereitungen zur topischen Anwendung“. Congratulations!
Wir freuen uns, Prof. Dr. Dagmar Fischer vom Department Chemie und Pharmazie der FAU am 08.01.2025 von 13:30 Uhr bis 14:30 Uhr bei uns begrüßen zu dürfen. Sie wird einen spannenden Vortrag mit dem Titel „Nano in der Pharmazie: Risiko, Perspektive oder nur Mythos?“ halten, zu dem wir sämtliche Intere...
Germany pledged to become climate neutral by 2045 with the amendment to the Climate Protection Act (Klimaschutzgesetz) and the more stringent climate protection provisions it contains. The Bavarian Climate Protection Act even stipulates that Bavaria must become climate neutral by 2040.
We support...
It is a pleasure for us to report together with our colleagues from Australia and Portugal new findings that underscore the need for innovative solutions and interdisciplinary collaboration to enhance the commercial viability and sustainability of bacterial cellulose.
For more information:
Nav...
At 22 November 2024 11 c.t. Prof. Fischer will give a lunch break seminar entiteled „Sustainability in pharmaceutical formulations“ in efs-NeW.
Further information:
Emil Fischer Graduate Programme / FAU NeW
A warm welcome to Francesca Mancusi from the University of Firenze! She joint our lab as visiting scientist for 6 months as part of her PhD thesis.
Francesca, we wish you a great and sucessfull time here in Erlangen!
